GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Denali Therapeutics Inc (FRA:4DN) » Definitions » Other Current Payables

Denali Therapeutics (FRA:4DN) Other Current Payables : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Denali Therapeutics Other Current Payables?

Denali Therapeutics's Other Current Payables for the quarter that ended in Mar. 2024 was €0.0 Mil.

Denali Therapeutics's quarterly Other Current Payables declined from Sep. 2023 (€9.7 Mil) to Dec. 2023 (€0.0 Mil) but then stayed the same from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€0.0 Mil).

Denali Therapeutics's annual Other Current Payables increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€4.1 Mil) but then declined from Dec. 2022 (€4.1 Mil) to Dec. 2023 (€0.0 Mil).


Denali Therapeutics Other Current Payables Historical Data

The historical data trend for Denali Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denali Therapeutics Other Current Payables Chart

Denali Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only - - - 4.14 -

Denali Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.97 6.44 9.70 - -

Denali Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Denali Therapeutics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Denali Therapeutics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Denali Therapeutics (FRA:4DN) Business Description

Traded in Other Exchanges
Address
161 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Denali Therapeutics (FRA:4DN) Headlines

No Headlines